A Study to Compare the Pharmacokinetics of BR4002 and BR4002-1 in Healthy Volunteers
Clinical trial NCT04462029 · COMPLETED
Trial details
- NCT number
- NCT04462029
- Sponsor
- Boryung Pharmaceutical Co., Ltd
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-05
- Primary completion
- 2020-10-07
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.